bluebird bio Inc (BLUE)
1.015
+0.06
(+6.51%)
USD |
NASDAQ |
Apr 19, 16:00
1.015
0.00 (0.00%)
After-Hours: 19:01
bluebird bio Gross Profit Margin (Quarterly): 11.60% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 11.60% |
| June 30, 2023 | -38.81% |
| March 31, 2023 | -41.79% |
| December 31, 2022 | 66.67% |
| September 30, 2022 | |
| June 30, 2022 | -14.88% |
| March 31, 2022 | -327.2% |
| December 31, 2021 | -129.2% |
| September 30, 2021 | -1.80K% |
| June 30, 2021 | -10.54K% |
| March 31, 2021 | 35.57% |
| December 31, 2020 | 98.38% |
| September 30, 2020 | 93.16% |
| Date | Value |
|---|---|
| June 30, 2020 | 99.22% |
| March 31, 2020 | 95.31% |
| December 31, 2019 | 94.51% |
| September 30, 2019 | 90.33% |
| June 30, 2019 | 95.39% |
| March 31, 2019 | 96.55% |
| December 31, 2018 | 95.75% |
| September 30, 2018 | 99.75% |
| June 30, 2018 | 99.73% |
| March 31, 2018 | 99.89% |
| December 31, 2017 | 99.83% |
| September 30, 2017 | 85.73% |
| June 30, 2017 | 97.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-10.54K%
Minimum
Jun 2021
99.22%
Maximum
Jun 2020
-712.6%
Average
35.57%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Agenus Inc | 20.07% |
| Motus GI Holdings Inc | -346.9% |
| Tivic Health Systems Inc | 1.40% |
| Vertex Pharmaceuticals Inc | 85.38% |
| AIM ImmunoTech Inc | 81.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.32% |
| Return on Assets | -14.97% |
| Return on Invested Capital | -37.32% |
| Profit Margin (Quarterly) | -578.8% |
| Operating Margin (Quarterly) | -683.7% |
| Return on Net Operating Assets | -26.68% |